A post on LinkedIn (about Cell-Ess) from Director at Bio-Technical Institute of Maryland

IS ANYONE INTERESTED IN USING A SERUM REPLACEMENT WITH A TRADITIONAL MEDIUM? A recent post in the  LinkedIn Group called Cell Culture Media and Feed reads: For special applications such as therapeutic protein or viral production, or maybe when cells might be the product, serum supplementation and addition of animal origin components is not desired for many reasons. Specialized serum-free media is available and it works very well. Most often, growth and performance surpass that seen when cells are grown in traditional media supplemented with serum. The problem however is that serum-free media is only formulated for a handful of
Continue

Brand Genius – Associate Product Manager/Product Manager needed

Are you a Marketing guru who understands what it takes to stand apart in the field of life-sciences and bio-pharmaceutical production? Are you a creative thinker, designer and implementer that can spread the word of our solutions to both customers and our sales team? A unique position has been created for you! We are taking both our Medical Division and Research Division and placing them under one umbrella for this position. You’ll work with our Managers and Sales Team(s) to provide educational and promotional materials to research labs, bio-pharmaceutical companies, hospitals, and surgeon’s. Your primary focus will be in the
Continue

Increasing Protein Production with Novel Cell-Ess Supplement without Affecting Metabolic Profile; a presentation that will be given at the upcoming BioProcessing Summit

At this years, always popular and always educational, BioProcessing Summit Meeting in Boston at the Westin Copley Place on August 5th, Adam Elhofy (PhD and CSO of Essential Pharmaceuticals) will be presenting on the topic of  Increasing Protein Production with Novel Cell Ess Supplement without Affecting Metabolic Profile. http://www.bioprocessingsummit.com/bioproduction “Enhancing protein production is a common goal in the bio-manufacturing industry. At a concentration of 1% Cell Ess supplement resulted in a 37% increase in productivity. When using the supplement as a feed it resulted in in a 25% increase in yield and an extension of peak protein production. Our results
Continue

The Economics of Reproducibility in Preclinical Research

We stumbled across an interesting paper by Leonard P. Freedman, Iain M. Cockburn, Timothy S. Simcoe Global Biological Standards Institute, Washington, D.C., United States of America, 2Boston University School of Management, Boston, Massachusetts, United States of America, Council of Economic Advisers, Washington, D.C., United States of America “Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the cumulative (total) prevalence of irreproducible preclinical research exceeds 50%, resulting in approximately US$28,000,000,000 (US $28B)/year spent on preclinical research that is not reproducible—in
Continue

Comparable outcome of liver transplantation with Histidine-Tryptophan-Ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial

Background                                                      The question of whether the choice of preservation solution affects outcome after liver transplantation is still not satisfactorily answered. The purpose of this study is to examine the preservation solutions? impact on outcome after liver transplantation. Methods A double-center retrospective study of short- and long-term results of 3134 consecutive liver transplantations with follow-up periods up to 23 years was performed applying multivariate, risk-adjusted analyses with a subset for living-donor transplants, pediatric transplants and cases with prolonged cold ischemic times. An additional focus was put on biliary complications. The primary study endpoints were short- and long-term patient survival and death-censored
Continue

Transplantation of a horseshoe kidney from a living donor: Case report, long term outcome and donor safety

The use of a horseshoe kidney in renal transplant remains controversial, when it is found in the evaluation of a living donor, anatomical, surgical and ethical issues are involved. A 51 year old woman was considered as a kidney donor to her 30 year-old son. Recipient was transplanted 11 years before with his father’s right kidney and implanted in the left side of the lower abdomen. After 10 years of adequate renal function, he developed chronic rejection and returned to hemodialysis. A new transplant was proposed and the mother was found to be the only available donor. Mother’s preoperative study
Continue

Let’s meet at the ATC – Corner Booth # 900

The American Transplant Congress is almost upon us and we are excited to see some old friends, meet some new friends and discuss studies, data and all things related to Organ Preservation Solution. In this, our 8th year of exhibiting at the ATC,… we are proud to represent such a tried and true product Custodiol HTK.    
Continue